Family history and biochemical diagnosis in 1948 kidney stone formers
Abstract
Introduction: The presence of family history of nephrolithiasis is associated with an increased risk of renal lithiasis. Different epidemiological studies have shown a family component in the incidence of it, which is independent of dietary and environmental factors. The role of heredity is evident in monogenic diseases such as cystinuria, Dent’s disease or primary hyperoxaluria, while a polygenic inheritance has been proposed to explain the tendency to form calcium oxalate stones. Objective: Our objective was to evaluate the family history of patients with renal lithiasis and the correlation of family history with its corresponding biochemical alteration, considering only those with a single metabolic alteration. Methods: a prospective and retrospective observational and analytical study that included 1948 adults over 17 years of age and a normal control group of 165 individuals, all evaluated according to an ambulatory protocol to obtain a biochemical diagnosis. They were asked about their family history of nephrolithiasis and classified into five groups according to the degree of kinship and the number of people affected in the family. Results: a positive family history of nephrolithiasis was found in 27.4% of renal stone formers, predominantly in women, compared to 15.2% of normal controls. The family history of nephrolithiasis was observed especially in 31.4% of patients with hypomagnesuria and in 29.6% of hypercalciuric patients. The rest of the biochemical alterations had a positive family history between 28.6% in hyperoxaluria and 21.9% in hypocitraturia. The highest percentage of family history of nephrolithiasis was found in cystinuria (75%) although there were few patients with this diagnosis. Conclusions: the inheritance has a clear impact on urolithiasis independently of the present biochemical alteration. Family history of nephrolithiasis of the first and second degree was observed between 21 and 32% of patients with renal lithiasis, with hypercalciuria and hypomagnesuria being the biochemical alterations with more family history.
References
Dallera JE, Chandhoke PS. Epidemiology and incidence of stone disease. En: Urinary stone disease: the practical guide to medical and surgical management / Marshall L. Stoller, Maxwell V. Meng, editors. Totowa, N.J.: Humana Press, 2007, p. 27.
Koyuncu HH, Yencilek F, Eryildirim B, Sarica K. Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence? Urol Res. 2010;38(2):105-9.
Ljunghall S, Danielson BG, Fellström B, Holmgren K, Johansson G, Wikström B. Family history of renal stones in recurrent stone patients. Br J Urol. 1985;57(4):370-4.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8(10):1568-73.
Trinchieri A, Mandressi A, Luongo P, Coppi F, Pisani E. Familial aggregation of renal calcium stone disease. J Urol. 1988;139(3):478-81.
Ahmadi Asr Badr Y, Hazhir S, Hasanzadeh K. Family history and age at the onset of upper urinary tract calculi. Urol J. 2007;4(3):142-5; discussion 145-6.
Guerra A, Folesani G, Nouvenne A, Ticinesi A, Allegri F, Pinelli S, et al. Family history influences clinical course of idiopathic calcium nephrolithiasis: case-control study of a large cohort of Italian patients. J Nephrol. 2016;29(5):645-51.
Shakhssalim N, Kazemi B, Basiri A, Houshmand M, Pakmanesh H, Golestan B, et al. Association between calcium-sensing receptor gene polymorphisms and recurrent calcium kidney stone disease: a comprehensive gene analysis. Scand J Urol Nephrol. 2010;44(6):406-12.
Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M, et al. An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Urol Res. 2011;39(1):1-7.
Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115(10):2598-608.
Goldfarb DS, Fischer ME, Keich Y, Goldberg J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 2005;67(3):1053-61.
Resnick M, Pridgen DB, Goodman HO. Genetic predisposition to formation of calcium oxalate renal calculi. N Engl J Med. 1968;278(24):1313-8.
Marickar YM, Salim A, Vijay A. Pattern of family history in stone patients. Urol Res. 2009;37(6):331-5.
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817-23.
Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisani E. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol. 2000;37(1):23-5.
Bartoletti R, Cai T, Mondaini N, Melone F, Travaglini F, Carini M, et al. Epidemiology and risk factors in urolithiasis. Urol Int. 2007;79(Suppl 1):3-7.
Pinduli I, Spivacow R, Del Valle E, Vidal S, Negri AL, Previgliano H, et al. Prevalence of urolithiasis in the autonomous city of Buenos Aires, Argentina. Urol Res. 2006;34(1):8-11.
Sakhaee K, Maalouf NM, Sinnott B. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012;97(6):1847-60.
Resnick M, Pridgen DB, Goodman HO. Genetic predisposition to formation of calcium oxalate renal calculi. N Engl J Med. 1968;278(24):1313-8.
Ljunghall S. Family history of renal stones in a population study of stone formers and healthy subjects. Br J Urol. 1979;51(4):249-52.
Spivacow FR, Del Valle EE, Negri AL, Fradinger E, Abib A, Rey P. Biochemical diagnosis in 3040 kidney stone formers in Argentina. Urolithiasis. 2015;43(4):323-30.
Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol. 2003;14(4):1082-95.
Van't Hoff WG. Aetiological factors in paediatric urolithiasis. Nephron Clin Pract. 2004;98(2):c45-8.
Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979;300(7):337-40.
Walker V, Cook P, Griffin DG. Characterisation of risk factors for stones in hyperuricosuric men attending a stone clinic. Urolithiasis. 2014;42(4):291-300.
Rhodes HL, Yarram-Smith L, Rice SJ, Tabaksert A, Edwards N, Hartley A, et al. Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol. 2015;10(7):1235-45.
Menè P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens. 2008;26(11):2085-92.
Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65(2):386-92.
